Skip to content
DataLookout
Menu

BASIS-2NCT07931885

Drug-coated Balloon Angioplasty For Ischemic Stroke Within 30 Days Caused By Intracranial Arterial Stenosis ( BASIS-2 )

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Any new stroke (ischemic/hemorrhagic stroke) and all-cause death within 30 days after enrollment or ischemic stroke in the target blood supply area within 31 days to 12 months after enrollment
Timeframe: Within 30 days after enrollment;Within 12 months after enrollment

Secondary (20)

Any stroke (ischemic/hemorrhagic stroke) and all-cause death within 30 days after enrollment
Any stroke (hemorrhagic/ischemic stroke) or death in the target vessel supply area within 90 days of enrollment
Any stroke (hemorrhagic/ischemic stroke) outside the target blood supply area within 90 days of enrollment
Assessment of neurological function improvement within 90 days of enrollment (mRS score)
Assessment of neurological function improvement within 180 days of enrollment (mRS score)
Show 15 moreShow less
Any stroke (hemorrhagic/ischemic stroke) or death in the target vascular supply area within 12 months of enrollment
Target vessel revascularization within 12 months of enrollment
Any stroke (hemorrhagic/ischemic stroke) outside the target blood supply area within 12 months of enrollment
Assessment of neurological function improvement within 12 months of enrollment (mRS score)
The incidence of vascular restenosis within 12 months of enrollment
Composite events such as stroke, myocardial infarction, and vascular death within 12 months of enrollment
Quality of life assessment within 12 months of enrollment (EQ-5D scale)
Any stroke (hemorrhagic/ischemic stroke) or death in the target vascular supply area within 24 months of enrollment
Any stroke (hemorrhagic/ischemic stroke) outside the target blood supply area within 24 months of enrollment
Assessment of neurological function improvement within 24 months of enrollment (mRS score)
Composite events such as stroke, myocardial infarction, and vascular death within 24 months of enrollment
Any stroke (hemorrhagic/ischemic stroke) or death in the target vascular supply area within 36 months of enrollment
Any stroke (hemorrhagic/ischemic stroke) outside the target vascular supply area within 36 months of enrollment
Assessment of neurological function improvement within 36 months of enrollment (mRS score)
Composite events such as stroke, myocardial infarction, and vascular death within 36 months of enrollment

Arms and interventions

Standard medical treatmentActive comparator
Intracranial artery durg-coated balloon dilatation combined with standard medical treatmentExperimental

Drugs: Drug therapy administration

Procedures: Intracranial artery balloon dilatation combined with intensive medical treatment

Sites

1 site in 1 country

  • Beijing Tiantan Hospital, Capital Medical UniversityBeijing, Beijing Municipality, China